Thrive Wealth Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Sell
3,977
-93
-2% -$28.2K 0.22% 54
2026
Q1
$870K Buy
4,070
+607
+18% +$136K 0.13% 82
2025
Q4
$593K Sell
3,463
-35
-1% -$5.44K 0.09% 114
2025
Q3
$468K Buy
3,498
+4
+0.1% +$424 0.07% 133
2025
Q2
$340K Buy
3,494
+87
+3% +$6.9K 0.05% 165
2025
Q1
$248K Buy
3,407
+529
+18% +$41.7K 0.05% 191
2024
Q4
$208K Sell
2,878
-412
-13% -$31.2K 0.04% 190
2024
Q3
$268K Sell
3,290
-750
-19% -$65.2K 0.05% 178
2024
Q2
$430K Buy
4,040
+220
+6% +$21.1K 0.08% 125
2024
Q1
$371K Buy
3,820
+780
+26% +$68.6K 0.08% 139
2023
Q4
$238K Buy
+3,040
New +$207K 0.05% 167
2023
Q3
Sell
-3,230
Closed -$208K 180
2023
Q2
$208K Buy
+3,230
New +$182K 0.05% 174

Other funds holding LRCX

Thrive Wealth Management's LRCX Position: Q2 2026 in Review

Thrive Wealth Management reduced its Lam Research (LRCX) stake by 2.3% in Q2 2026, selling an estimated $28.2K and leaving 3,977 shares worth $1.72M. The position accounts for 0.22% of the portfolio, ranked #54.

Thrive Wealth Management first reported a position in LRCX in Q2 2023 and has held it in 12 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Thrive Wealth Management held 3,977 shares of Lam Research worth $1.72M as of Q2 2026.
  • Thrive Wealth Management sold 93 Lam Research shares in Q2 2026, an estimated $28.2K.
  • Lam Research made up 0.22% of Thrive Wealth Management's portfolio in Q2 2026, its #54 holding.
  • Thrive Wealth Management first reported a position in Lam Research in Q2 2023 and has held it in 12 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.